Infertility Treatment Market Emerging Demand and Growth in Coming Year

Infertility is a condition where, a person is unable to reproduce by natural means. Treatment of the infertility depends on the cause of the condition. The various causes of infertility include sexually transmitted infections, genetic problems, DNA damage due to smoking, diabetes mellitus, and toxins such as chemical dusts, glues and pesticides. According to the Center for Disease Control and Prevention (CDC), there are around 6.9 million women aged 15-44 years, who have ever used infertility services. The global infertility treatment market is increasing significantly due to the changing lifestyle and exposure to harmful chemicals via pollution.

Based on the product, the infertility market is segmented into instruments, media & consumables, and accessories. Instruments accounted for the largest share in the infertility market in 2016, due to its application in wide range of treatment processes such as surgery, intrauterine insemination, in vitro fertilization, and intracytoplasmic sperm injection.

Access Report Overview : https://www.psmarketresearch.com/market-analysis/infertility-treatment-market

infertility treatment market is expected to grow significantly during the forecast period (2017-2023). The major factors driving growth of the infertility treatment market are continuous decline in fertility rates, high prevalence of lifestyle disorders, growing public awareness about infertility and the available treatment options, and technological advancements in infertility treatment devices.

Smoking is one of the major reasons for the decline in fertility rates and high prevalence of lifestyle disorders. According to the Center for Disease Control & Prevention (CDC), smoking kills more than 480,000 people every year in the U.S. Smoking reduces fertility in female ovocytes and in male sperm. As per the reports of World Health Organization (WHO), every year tobacco kills more than 7 million people worldwide. Thus, the various disorders caused by the smoking and decline in the fertility rate are driving the growth of the infertility treatment market.

Download Sample : https://www.psmarketresearch.com/market-analysis/infertility-treatment-market/report-sample

Healthcare industry is undergoing rapid changes in the emerging economies due to rising government expenditure, increasing number of hospitals, increase in the number of surgeries, and rising healthcare awareness. Emerging economies provide a suitable opportunity for the growth of the infertility treatment market. In emerging economies such as India, China, Brazil, and Mexico, government is increasingly spending on the healthcare. According to World Bank, Brazil spent 8.3% of $2.456 trillion GDP on healthcare in 2014. Similarly, China spent 5.5% of its GDP on healthcare, whereas, Mexico spent 6.3% of GDP on healthcare, in 2014.

Asia-Pacific is expected to witness the fastest growth in the forecasted period (2017-2023), due to the increasing medical tourism, growing healthcare expenditure, increasing population, and reduction in treatment prices.

Pre-Purchase Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=infertility-treatment-market

Some of the key players in the infertility treatment market include Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Genea Limited, Irvine Scientific, The Baker Company, Inc., IVFtech ApS, Esco Micro Pte. Ltd., Thermo Fisher Scientific, Inc., and Labotect GmbH.

The key players are expanding their presence in the market by making strategic acquisition. In November 2016, Cooper Companies, Inc. announced that CooperSurgical had acquired Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc. The purchase price was approximately $168 million subject to customary closing adjustments. The acquisition was a strategic fit with the existing IVF portfolio as Wallace was expected to bring the gold standard of embryo transfer catheters along with several other premier products such as oocyte retrieval needles.

In May 2016, Cooper Companies, Inc. CooperSurgical had acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening. The acquisition was an exceptional fit for CooperSurgical as it adds the premier carrier screening test sold within the IVF marketplace to the existing IVF genetic testing platform.

About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.